| Genetic Association of Advanced Prostate Cancer to Fragile Histidine Triad Gene (FHIT) |
Yan Ding |
City of Hope |
PLCO |
Aug 11, 2011 |
2011-0120 |
| Prediction of true positive lung cancer in abnormal suspicious CXR lung screens |
Martin Tammemagi |
Brock University |
NLST |
Aug 2, 2011 |
201108-0010 |
| Collaborative Group on Epidemiological Studies of Female Cancers |
Amanda Black |
NCI, DCEG, EBP |
PLCO |
Jul 21, 2011 |
2011-0182 |
| Place of birth, race-ethnicity and the risk of colorectal neoplasia |
Adeyinka Laiyemo |
NCI, DCP, BRG |
PLCO |
Jun 9, 2011 |
2011-0067 |
| Analysis of compliance and retention for the PLCO cohort |
Brendan Murphy |
Booz Allen Hamilton |
PLCO |
Jun 6, 2011 |
2011-0090 |
| Screening interval based on initial PSA: Data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial |
Zaina Qureshi |
South Carolina College of Pharmacy, University of South Carolina |
PLCO |
May 19, 2011 |
2011-0087 |
| Predicting how the ROCA algorithm would have performed in PLCO |
Paul Pinsky |
NCI, DCP, EDRG |
PLCO |
May 19, 2011 |
2011-0089 |
| Prediction of true positive lung cancer in abnormal suspicious CT lung screens |
Martin Tammemagi |
Henry Ford Health System |
NLST |
May 17, 2011 |
201105-0015 |
| Genome-wide Association Study of Benign Prostatic Hyperplasia |
Sonja Berndt |
NCI, DCEG, OEEB |
PLCO |
Apr 20, 2011 |
2011-0078 |
| Coffee, tea, caffeine and the risk of cancer |
Mia Hashibe |
University of Utah |
PLCO |
Apr 4, 2011 |
2011-0052 |
| Prostate cancer risk in relation to obesity and diabetes: A pooled analysis (Cohort Consortium Study) |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Mar 25, 2011 |
2011-0053 |
| KIR/HLA/MIR148A variation and risk of prostate cancer |
Stella Koutros |
NCI, DCEG, OEEB |
PLCO |
Mar 9, 2011 |
2011-0039 |
| Mitochondrial DNA Copy Number and Prostate Cancer Risk |
Sonja Berndt |
NCI, DCEG, OEEB |
PLCO |
Mar 9, 2011 |
2011-0037 |
| Risk of multiple myeloma in relation to plasma adipokine levels: a nested case-control study in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Jonathan Hofmann |
DCEG - Other |
PLCO |
Mar 9, 2011 |
2011-0028 |
| Prostate Cancer Survival in PLCO: The effect of screening |
Paul Pinsky |
NCI, DCP, EDRG |
PLCO |
Mar 3, 2011 |
2010-0301 |
| Risk factors for endometrial cancer in black and white women in the Epidemiology of Endometrial Cancer Consortium (E2C2) |
Sara Olson |
Memorial Sloan-Kettering Cancer Center |
PLCO |
Feb 2, 2011 |
2010-0290 |
| Oxford Pooling Project: Prostate (endogenous hormones and nutritional biomarkers) |
Amanda Black |
NCI, DCEG, EBP |
PLCO |
Jan 31, 2011 |
2010-0320 |
| Inflammatory Markers and Subsequent Risk of Prostate Cancer |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Jan 20, 2011 |
2010-0034 |
| CT Individual Dose Project |
Randell Kruger |
Marshfield Clinic Research Foundation |
NLST |
Dec 28, 2010 |
201012-0028 |
| Side-effects and complications of prostate biopsies, radical prostatectomies and prostate cancer diagnoses within the PLCO Trial |
Amanda Black |
NCI, DCEG, EBP |
PLCO |
Nov 23, 2010 |
2010-0265 |
